Reuters -
7 Jan 2019 17:03
The U.S. Supreme Court on Monday declined to take up Amgen Inc's bid to reinstate a jury verdict it won against rivals Regeneron Pharmaceuticals Inc and Sanofi SA in patent dispute over cholesterol medication.
Share this Article